West Pharmaceutical Services | WST - Assets


West Pharmaceutical Services reported $4.06B in Assets for its fiscal quarter ending in September of 2026.





Assets Change Date
Align Technology USD 6.52B 103.03M Sep/2026
Baxter International USD 19.41B 377M Sep/2026
Becton, Dickinson and Co. USD 50.79B 60M Sep/2026
Cerus USD 221.86M 6.67M Dec/2025
Charles River Laboratories USD 7.45B 80.64M Sep/2026
Cooper Companies USD 12.67B 191.1M Jun/2026
Dentsply International USD 5.19B 14M Sep/2026
Haemonetics USD 2.41B 45.2M Sep/2026
ICU Medical USD 3.94B 27.48M Sep/2026
Insulet USD 3.42B 250M Sep/2026
Integra LifeSciences USD 3.51B 55.69M Sep/2026
IQVIA Holdings USD 30.47B 593M Sep/2026
J&J USD 197.42B 3.64B Sep/2026
Medtronic USD 93.31B 278M Jun/2026
Merit Medical Systems USD 2.92B 61.29M Sep/2026
Neogen USD 3.3B 42.8M Jun/2026
OraSure Technologies USD 360.55M 18.62M Jun/2026
Quidel USD 5.78B 66M Sep/2026
Repligen USD 2.93B 23.77M Sep/2026
Rockwell Medical USD 52.62M 1.34M Jun/2025
Solventum Corp USD 14.16B 78M Sep/2026
STAAR Surgical USD 485.16M 9.95M Sep/2026
Terumo JPY 2.37T 61.86B Jun/2026
Utah Medical Products USD 124.38M 1.84M Mar/2026
West Pharmaceutical Services USD 4.06B 15.7M Sep/2026